Successful treatment with anti-CD20 monoclonal antibody (rituximab) of life-threatening refractory systemic lupus erythematosus with renal and central nervous system involvement.

• Authors: K Saito, M Nawata, S Nakayamada, M Tokunaga, J Tsukada, Y Tanaka
• Journal: Lupus (Lupus) Vol. 12 Issue 10 Pg. 798-800 ( 2003) ISSN: 0961-2033 [Print] England
• PMID: 14596432 (Publication Type: Case Reports, Letter)

Chemical References

• Antibodies, Monoclonal
• Antibodies, Monoclonal, Murine-Derived
• Antigens, CD20
• Antineoplastic Agents
• Immunosuppressive Agents
• Rituximab

Topics

• Adult
• Antibodies, Monoclonal (therapeutic use)
• Antibodies, Monoclonal, Murine-Derived
• Antigens, CD20 (immunology)
• Antineoplastic Agents (therapeutic use)
• Female
• Humans
• Immunosuppressive Agents (therapeutic use)
• Lupus Vasculitis, Central Nervous System (drug therapy)
• Rituximab